Mark Kessel - Net Worth and Insider Trading
Mark Kessel Net Worth
The estimated net worth of Mark Kessel is at least $3 Million dollars as of 2024-09-20. Mark Kessel is the Director of Dynavax Technologies Corp and owns about 303,143 shares of Dynavax Technologies Corp (DVAX) stock worth over $3 Million. Details can be seen in Mark Kessel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Kessel has not made any transactions after 2012-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Kessel
Mark Kessel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Kessel owns 5 companies in total, including Organovo Holdings Inc (ONVO) , Dynavax Technologies Corp (DVAX) , and Oncotelic Therapeutics Inc (OTLC) among others .
Click here to see the complete history of Mark Kessel’s form 4 insider trades.
Insider Ownership Summary of Mark Kessel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONVO | Organovo Holdings Inc | 2016-08-17 | director |
| DVAX | Dynavax Technologies Corp | 2012-10-16 | director |
| OTLC | Oncotelic Therapeutics Inc | 2010-07-01 | director & 10 percent owner |
 | | 2009-08-26 | 10 percent owner & other: See Footnote 2 and Remarks |
| | 2004-05-27 | director |
Mark Kessel Latest Holdings Summary
Mark Kessel currently owns a total of 1 stock. Mark Kessel owns 303,143 shares of Dynavax Technologies Corp (DVAX) as of October 16, 2012, with a value of $3 Million.
Latest Holdings of Mark Kessel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DVAX | Dynavax Technologies Corp | 2012-10-16 | 303,143 | 11.47 | 3,477,050 |
Holding Weightings of Mark Kessel
Mark Kessel Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Kessel has made a total of 0 transactions in Dynavax Technologies Corp (DVAX) over the past 5 years. The most-recent trade in Dynavax Technologies Corp is the sale of 600,000 shares on October 16, 2012, which brought Mark Kessel around $28 Million.
Insider Trading History of Mark Kessel
- 1
Mark Kessel Trading Performance
Mark Kessel Ownership Network
Mark Kessel Owned Company Details
What does Organovo Holdings Inc do?
Who are the key executives at Organovo Holdings Inc?
Mark Kessel is the director of Organovo Holdings Inc. Other key executives at Organovo Holdings Inc include President & CFO and PFO Thomas Hess , General Counsel & Secretary Thomas E Jurgensen , and Chief Scientific Officer Jeffrey N. Miner .
Organovo Holdings Inc (ONVO) Insider Trades Summary
Over the past 18 months, Mark Kessel made no insider transaction in Organovo Holdings Inc (ONVO). Other recent insider transactions involving Organovo Holdings Inc (ONVO) include a net sale of 19,607 shares made by David Gobel ,
In summary, during the past 3 months, insiders sold 0 shares of Organovo Holdings Inc (ONVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,607 shares of Organovo Holdings Inc (ONVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,607 shares.
Organovo Holdings Inc (ONVO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Organovo Holdings Inc Insider Transactions
Mark Kessel Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Kessel. You might contact Mark Kessel via mailing address: 950 Park Ave Apt. 11a, New York Ny 10028.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
